Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
211-225 of 618
Rethinking Lupus Nephritis: Targeting Immune Dysfunction
Living RheumRethinking Lupus Nephritis: Targeting Immune Dysfunction
Joan Merrill, MD
Recognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Clinician's RoundtableRecognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
Ryan Quigley
Understanding Pediatric Eye Disorders: Key Insights from AAP 2025
Clinician's RoundtableUnderstanding Pediatric Eye Disorders: Key Insights from AAP 2025
Laura B. Enyedi, MD
Pediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
Clinician's RoundtablePediatric RSV Hospitalizations Reveal Shifting Risk Profiles Post-Pandemic
Rethinking Chronic Pain: A Biopsychosocial Approach to Management
Living RheumRethinking Chronic Pain: A Biopsychosocial Approach to Management
Martin Cheatle, PhD
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiersDecoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Ryan Quigley
- advertisement
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiersTiming Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Hallie Blevins, PhD
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Ryan Quigley
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiersClemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Reimagining Autoimmune Care with CAR-Based Cell Therapies
Living RheumReimagining Autoimmune Care with CAR-Based Cell Therapies
Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Project Oncology®Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study
Marlene Mimi Maeusli, PhD.
- advertisement
Targeting CD19 in Autoimmune Neuropathy: Case Report Insights
Living RheumTargeting CD19 in Autoimmune Neuropathy: Case Report Insights
Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Project Oncology®Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers
Paola Marignani, PhD, EMBA
From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Project Oncology®From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
Ryan Quigley
